Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (15022)
All Articles published online
|
Publishing Process of This Article
|
Sep 14, 2014 (publication date) through Apr 18, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Hassan K, Bhalla V, Regal MEE, A-Kader HH. Nonalcoholic fatty liver disease: A comprehensive review of a growing epidemic. World J Gastroenterol 2014; 20(34): 12082-12101 [PMID: 25232245 DOI: 10.3748/wjg.v20.i34.12082] |
|---|---|
| URL: | https://www.wjgnet.com/2220-3214/full/v20/i34/12082.htm |
| Number | Citing Articles |
| 1 |
Ha-Neul Choi, Jin-Yeong Shin, Jung-In Kim. Ameliorative Effect of Myricetin on Nonalcoholic Fatty Liver Disease in ob/ob Mice. Journal of Medicinal Food 2021; 24(10): 1092 doi: 10.1089/jmf.2021.K.0090
|
| 2 |
Ghulam Fatima, Kaneez Zainab Rabail, Mona Humaira, Afsana Khaskheli, Benazir Bughio, Kashaf Nida. Frequency of Liver Fibrosis by Non Invasive Marker in Patients with Non-Alcohol Fatty Liver Diseases. Pakistan Journal of Health Sciences 2023; : 99 doi: 10.54393/pjhs.v4i02.572
|
| 3 |
Elena Buzzetti, Massimo Pinzani, Emmanuel A. Tsochatzis. The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD). Metabolism 2016; 65(8): 1038 doi: 10.1016/j.metabol.2015.12.012
|
| 4 |
Bubu A. Banini, Arun J. Sanyal. Nonalcoholic Fatty Liver Disease: Epidemiology, Pathogenesis, Natural History, Diagnosis, and Current Treatment Options. Clinical Medicine Insights: Therapeutics 2016; 8: CMT.S18885 doi: 10.4137/CMT.S18885
|
| 5 |
O. M. Drapkina, R. N. Shepel, E. P. Yakovenko, E. V. Zyatenkova. Non-invasive methods for detection of progressive fibrosis in patients with nonalcoholic fat liver disease. Profilakticheskaya meditsina 2019; 22(2): 82 doi: 10.17116/profmed20192202182
|
| 6 |
Banrida Wahlang, Jordan T. Perkins, Michael C. Petriello, Jessie B. Hoffman, Arnold J. Stromberg, Bernhard Hennig. A compromised liver alters polychlorinated biphenyl-mediated toxicity. Toxicology 2017; 380: 11 doi: 10.1016/j.tox.2017.02.001
|
| 7 |
Tsuyoshi Uchida, Koichi Fujiwara, Kenichi Nishioji, Masao Kobayashi, Manabu Kano, Yuya Seko, Kanji Yamaguchi, Yoshito Itoh, Hiroshi Kadotani. Medical checkup data analysis method based on LiNGAM and its application to nonalcoholic fatty liver disease. Artificial Intelligence in Medicine 2022; 128: 102310 doi: 10.1016/j.artmed.2022.102310
|
| 8 |
Reshmi Morris, Ronald Feinstein, Martin Fisher. Laboratory screening in overweight/obese adolescents: do the results change the management?. International Journal of Adolescent Medicine and Health 2017; 29(5) doi: 10.1515/ijamh-2015-0102
|
| 9 |
Jiajing Zhao, Yingjue Wang, Xi Wu, Ping Tong, Yaohan Yue, Shurong Gao, Dongping Huang, Jianwei Huang. Inhibition of CCL19 benefits non‑alcoholic fatty liver disease by inhibiting TLR4/NF‑κB‑p65 signaling. Molecular Medicine Reports 2018; doi: 10.3892/mmr.2018.9490
|
| 10 |
Dengcheng Hui, Lu Liu, Nisma Lena Bahaji Azami, Jingru Song, Yanping Huang, Wan Xu, Chao Wu, Dong Xie, Yulang Jiang, Yanqin Bian, Mingyu Sun. The spleen-strengthening and liver-draining herbal formula treatment of non-alcoholic fatty liver disease by regulation of intestinal flora in clinical trial. Frontiers in Endocrinology 2023; 13 doi: 10.3389/fendo.2022.1107071
|
| 11 |
Lan N. Tu, Megan R. Showalter, Tomas Cajka, Sili Fan, Viju V. Pillai, Oliver Fiehn, Vimal Selvaraj. Metabolomic characteristics of cholesterol-induced non-obese nonalcoholic fatty liver disease in mice. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-05040-6
|
| 12 |
Mi Ji Jeong, Sang Ryong Kim, Un Ju Jung. Schizandrin A supplementation improves nonalcoholic fatty liver disease in mice fed a high-fat and high-cholesterol diet. Nutrition Research 2019; 64: 64 doi: 10.1016/j.nutres.2019.01.001
|
| 13 |
Po-Hsiang Tsui, Yung-Liang Wan. Effects of Fatty Infiltration of the Liver on the Shannon Entropy of Ultrasound Backscattered Signals. Entropy 2016; 18(9): 341 doi: 10.3390/e18090341
|
| 14 |
Tae-In Hwang, A-Lum Han. Quality of Life in Adults with Metabolic Dysfunction-Associated Fatty Liver Disease. International Journal of Environmental Research and Public Health 2021; 18(24): 13145 doi: 10.3390/ijerph182413145
|
| 15 |
Polyana C. Marinho, Aline B. Vieira, Priscila G. Pereira, Kíssila Rabelo, Bianca T. Ciambarella, Ana L. R. Nascimento, Erika Cortez, Aníbal S. Moura, Fernanda V. Guimarães, Marco A. Martins, Gonzalo Barquero, Rodrigo N. Ferreira, Jorge J. de Carvalho. Capybara Oil Improves Hepatic Mitochondrial Dysfunction, Steatosis, and Inflammation in a Murine Model of Nonalcoholic Fatty Liver Disease. Evidence-Based Complementary and Alternative Medicine 2018; 2018: 1 doi: 10.1155/2018/4956079
|
| 16 |
Emma J. Robinson, Matthew C. Taddeo, Xin Chu, Weixing Shi, Craig Wood, Christopher Still, Virginia G. Rovnyak, David Rovnyak. Aqueous Metabolite Trends for the Progression of Nonalcoholic Fatty Liver Disease in Female Bariatric Surgery Patients by Targeted 1H-NMR Metabolomics. Metabolites 2021; 11(11): 737 doi: 10.3390/metabo11110737
|
| 17 |
Nengguang Fan, Lijuan Zhang, Zhenhua Xia, Liang Peng, Yufan Wang, Yongde Peng. Sex-Specific Association between Serum Uric Acid and Nonalcoholic Fatty Liver Disease in Type 2 Diabetic Patients. Journal of Diabetes Research 2016; 2016: 1 doi: 10.1155/2016/3805372
|
| 18 |
Mélanie Kirchmeyer, Florence A Servais, Matthias Hamdorf, Petr V Nazarov, Aurélien Ginolhac, Rashi Halder, Laurent Vallar, Matthias Glanemann, Claudia Rubie, Frank Lammert, Stephanie Kreis, Iris Behrmann. Cytokine-mediated modulation of the hepatic miRNome: miR-146b-5p is an IL-6-inducible miRNA with multiple targets. Journal of Leukocyte Biology 2018; 104(5): 987 doi: 10.1002/JLB.MA1217-499RR
|
| 19 |
Lu Gan, Zi-jun Meng, Ri-bo Xiong, Jin-qiang Guo, Xiao-cui Lu, Zhi-wei Zheng, Yan-ping Deng, Bing-de Luo, Fei Zou, Hua Li. Green tea polyphenol epigallocatechin-3-gallate ameliorates insulin resistance in non-alcoholic fatty liver disease mice. Acta Pharmacologica Sinica 2015; 36(5): 597 doi: 10.1038/aps.2015.11
|
| 20 |
Richard M. Woodford, Paul R. Burton, Paul E. O’Brien, Cheryl Laurie, Wendy A. Brown. Laparoscopic Adjustable Gastric Banding In Patients with Unexpected Cirrhosis: Safety and Outcomes. Obesity Surgery 2015; 25(10): 1858 doi: 10.1007/s11695-015-1623-9
|
| 21 |
Sofia G. Verstraete, Janet M. Wojcicki, Emily R. Perito, Philip Rosenthal. Bisphenol a increases risk for presumed non-alcoholic fatty liver disease in Hispanic adolescents in NHANES 2003–2010. Environmental Health 2018; 17(1) doi: 10.1186/s12940-018-0356-3
|
| 22 |
Zhuhuang Zhou, Dar-In Tai, Yung-Liang Wan, Jeng-Hwei Tseng, Yi-Ru Lin, Shuicai Wu, Kuen-Cheh Yang, Yin-Yin Liao, Chih-Kuang Yeh, Po-Hsiang Tsui. Hepatic Steatosis Assessment with Ultrasound Small-Window Entropy Imaging. Ultrasound in Medicine & Biology 2018; 44(7): 1327 doi: 10.1016/j.ultrasmedbio.2018.03.002
|
| 23 |
Ziqi Chen, Fang Liu, Nanxin Zheng, Meng Guo, Leilei Bao, Yangyang Zhan, Mingjian Zhang, Yuanyu Zhao, Wenyuan Guo, Guoshan Ding. Wuzhi capsule (Schisandra Sphenanthera extract) attenuates liver steatosis and inflammation during non-alcoholic fatty liver disease development. Biomedicine & Pharmacotherapy 2019; 110: 285 doi: 10.1016/j.biopha.2018.11.069
|
| 24 |
Man Gong, Chengfu Su, Mengzhe Fan, Ping Wang, Bingdi Cui, Zhongyuan Guo, Shaojia Liang, Lianhe Yang, Xiaoqian Liu, Liping Dai, Zhimin Wang. Mechanism by which Eucommia ulmoides leaves Regulate Nonalcoholic fatty liver disease based on system pharmacology. Journal of Ethnopharmacology 2022; 282: 114603 doi: 10.1016/j.jep.2021.114603
|
| 25 |
Long Wang, Jinghui Guo, Jianping Lu. Risk factor compositions of nonalcoholic fatty liver disease change with body mass index in males and females. Oncotarget 2016; 7(24): 35632 doi: 10.18632/oncotarget.9691
|
| 26 |
Ewa Stachowska, Karina Ryterska, Dominika Maciejewska, Marcin Banaszczak, Piotr Milkiewicz, Małgorzata Milkiewicz, Izabela Gutowska, Piotr Ossowski, Małgorzata Kaczorowska, Dominika Jamioł-Milc, Anna Sabinicz, Małgorzata Napierała, Lidia Wądołowska, Joanna Raszeja-Wyszomirska. Nutritional Strategies for the Individualized Treatment of Non-Alcoholic Fatty Liver Disease (NAFLD) Based on the Nutrient-Induced Insulin Output Ratio (NIOR). International Journal of Molecular Sciences 2016; 17(7): 1192 doi: 10.3390/ijms17071192
|
| 27 |
Llilda Barata, Mary F. Feitosa, Lawrence F. Bielak, Brian Halligan, Abigail S. Baldridge, Xiuqing Guo, Laura M. Yerges‐Armstrong, Albert V. Smith, Jie Yao, Nicholette D. Palmer, Lisa B. VanWagner, J. Jeffrey Carr, Yii‐Der I. Chen, Matthew Allison, Matthew J. Budoff, Samuel K. Handelman, Sharon L.R. Kardia, Thomas H. Mosley, Kathleen Ryan, Tamara B. Harris, Lenore J. Launer, Vilmundur Gudnason, Jerome I. Rotter, Myriam Fornage, Laura J. Rasmussen‐Torvik, Ingrid B. Borecki, Jeffrey R. O’Connell, Patricia A. Peyser, Elizabeth K. Speliotes, Michael A. Province. Insulin Resistance Exacerbates Genetic Predisposition to Nonalcoholic Fatty Liver Disease in Individuals Without Diabetes. Hepatology Communications 2019; 3(7): 894 doi: 10.1002/hep4.1353
|
| 28 |
Rong Zhang, Keran Cheng, Shizan Xu, Sainan Li, Yuqing Zhou, Shunfeng Zhou, Rui Kong, Linqiang Li, Jingjing Li, Jiao Feng, Liwei Wu, Tong Liu, Yujing Xia, Jie Lu, Chuanyong Guo, Yingqun Zhou. Metformin and Diammonium Glycyrrhizinate Enteric-Coated Capsule versus Metformin Alone versus Diammonium Glycyrrhizinate Enteric-Coated Capsule Alone in Patients with Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus. Gastroenterology Research and Practice 2017; 2017: 1 doi: 10.1155/2017/8491742
|
| 29 |
Mazen Noureddin, Alice Zhang, Rohit Loomba. Promising therapies for treatment of nonalcoholic steatohepatitis. Expert Opinion on Emerging Drugs 2016; 21(3): 343 doi: 10.1080/14728214.2016.1220533
|
| 30 |
Kimberley D. Bruce, Dawid Szczepankiewicz, Kiran K. Sihota, Manoj Ravindraanandan, Hugh Thomas, Karen A. Lillycrop, Graham C. Burdge, Mark A. Hanson, Christopher D. Byrne, Felino R. Cagampang. Altered cellular redox status, sirtuin abundance and clock gene expression in a mouse model of developmentally primed NASH. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2016; 1861(7): 584 doi: 10.1016/j.bbalip.2016.03.026
|
| 31 |
Shoukat Ali Samejo, Zaigham Abbas, Muhammad Asim. Effects of anthropometric and metabolic parameters on transaminase levels and liver stiffness in patients with non-alcohol fatty liver disease. Tropical Doctor 2021; 51(2): 185 doi: 10.1177/0049475520962742
|
| 32 |
Zeyu Li, Hong Wang, Kanglin Wu, Lianfeng Zhang. Omarigliptin protects against nonalcoholic fatty liver disease by ameliorating oxidative stress and inflammation. Journal of Biochemical and Molecular Toxicology 2021; 35(12) doi: 10.1002/jbt.22914
|
| 33 |
Manash Pratim Pathak, Kalyani Pathak, Riya Saikia, Urvashee Gogoi, Pompy Patowary, Pronobesh Chattopadhyay, Aparoop Das. Therapeutic potential of bioactive phytoconstituents found in fruits in the treatment of non-alcoholic fatty liver disease: A comprehensive review. Heliyon 2023; 9(4): e15347 doi: 10.1016/j.heliyon.2023.e15347
|
| 34 |
Laurent Dollé, Neil D. Theise, Eva Schmelzer, Luke Boulter, Olivier Gires, Leo A. van Grunsven. EpCAM and the biology of hepatic stem/progenitor cells. American Journal of Physiology-Gastrointestinal and Liver Physiology 2015; 308(4): G233 doi: 10.1152/ajpgi.00069.2014
|
| 35 |
Bin Li, Qi Xiao, Jianuo Zhang, Yumeng Wang, Jiushi Liu, Bengang Zhang, Haitao Liu. Exploring the active compounds and potential mechanism of the anti-nonalcoholic fatty liver disease activity of the fraction from Schisandra chinensis fruit extract based on multi-technology integrated network pharmacology. Journal of Ethnopharmacology 2023; 301: 115769 doi: 10.1016/j.jep.2022.115769
|
| 36 |
Nicolai Worm. Schützt moderater Weinkonsum vor nichtalkoholischer Fettleber?. 38th World Congress of Vine and Wine (Part 2) 2015; : 08001 doi: 10.1051/oivconf/201508001
|
| 37 |
Nicolai Worm. Schützt moderater Weinkonsum vor nichtalkoholischer Fettleber?. 38th World Congress of Vine and Wine (Part 2) 2015; : 08001 doi: 10.1051/oivconf/201508001
|
| 38 |
Arshad Mehmood, Lei Zhao, Yong Wang, Fei Pan, Shuai Hao, Huimin Zhang, Asra Iftikhar, Muhammad Usman. Dietary anthocyanins as potential natural modulators for the prevention and treatment of non-alcoholic fatty liver disease: A comprehensive review. Food Research International 2021; 142: 110180 doi: 10.1016/j.foodres.2021.110180
|
| 39 |
Lauren Weaver, Abdul-rizaq Hamoud, David E. Stec, Terry D. Hinds. Biliverdin reductase and bilirubin in hepatic disease. American Journal of Physiology-Gastrointestinal and Liver Physiology 2018; 314(6): G668 doi: 10.1152/ajpgi.00026.2018
|
| 40 |
Yue Liu, Jian-Ying Sheng, Chun-Fang Yang, Junjun Ding, Yun-Shen Chan. A decade of liver organoids: Advances in disease modeling. Clinical and Molecular Hepatology 2023; 29(3): 643 doi: 10.3350/cmh.2022.0428
|
| 41 |
Lijing Zhang, Bin Yang, Baoping Yu. Paeoniflorin Protects against Nonalcoholic Fatty Liver Disease Induced by a High-Fat Diet in Mice. Biological & Pharmaceutical Bulletin 2015; 38(7): 1005 doi: 10.1248/bpb.b14-00892
|
| 42 |
Steven E. Trasino, Xiao-Han Tang, Jose Jessurun, Lorraine J. Gudas. A retinoic acid receptor β2 agonist reduces hepatic stellate cell activation in nonalcoholic fatty liver disease. Journal of Molecular Medicine 2016; 94(10): 1143 doi: 10.1007/s00109-016-1434-z
|
| 43 |
Amina A. Negash, Michael Gale. Hepatitis regulation by the inflammasome signaling pathway. Immunological Reviews 2015; 265(1): 143 doi: 10.1111/imr.12279
|
| 44 |
Nengguang Fan, Liang Peng, Zhenhua Xia, Lijuan Zhang, Yufan Wang, Yongde Peng. Helicobacter pylori Infection Is Not Associated with Non-alcoholic Fatty Liver Disease: A Cross-Sectional Study in China. Frontiers in Microbiology 2018; 9 doi: 10.3389/fmicb.2018.00073
|
| 45 |
Yvonne Alt, Jörn M. Schattenberg. Derzeit bleiben als Gegenmittel nur Aufmerksamkeit und Lebensstilmodifikation. Info Diabetologie 2015; 9(1): 28 doi: 10.1007/s15034-014-0624-4
|
| 46 |
Rendong Ren, Junjie Gong, Yanyan Zhao, Xinyun Zhuang, Yin Ye, Wenting Lin. Sulfated polysaccharides from Enteromorpha prolifera suppress SREBP-2 and HMG-CoA reductase expression and attenuate non-alcoholic fatty liver disease induced by a high-fat diet. Food & Function 2017; 8(5): 1899 doi: 10.1039/C7FO00103G
|
| 47 |
Qian He, Xuan Xia, Kecheng Yao, Jun Zeng, Wei Wang, Qiong Wu, Renmin Tang, Xiulan Zou. Amlexanox reversed non-alcoholic fatty liver disease through IKKε inhibition of hepatic stellate cell. Life Sciences 2019; 239: 117010 doi: 10.1016/j.lfs.2019.117010
|
| 48 |
WEI CHEN, XIAOWEI WANG, LI HUANG, BO LIU. Hepcidin in non-alcoholic fatty liver disease regulated by the TLR4/NF-κB signaling pathway. Experimental and Therapeutic Medicine 2016; 11(1): 73 doi: 10.3892/etm.2015.2873
|
| 49 |
José A Del Campo, Paloma Gallego, Lourdes Grande. Role of inflammatory response in liver diseases: Therapeutic strategies. World Journal of Hepatology 2018; 10(1): 1-7 doi: 10.4254/wjh.v10.i1.1
|
| 50 |
Stephen I. Johnson, Daniel Fort, Kenneth J. Shortt, George Therapondos, Gretchen E. Galliano, Theresa Nguyen, Edward I. Bluth. Ultrasound Stratification of Hepatic Steatosis Using Hepatorenal Index. Diagnostics 2021; 11(8): 1443 doi: 10.3390/diagnostics11081443
|
| 51 |
Fernando Ezquer, Javiera Bahamonde, Ya-Lin Huang, Marcelo Ezquer. Administration of multipotent mesenchymal stromal cells restores liver regeneration and improves liver function in obese mice with hepatic steatosis after partial hepatectomy. Stem Cell Research & Therapy 2017; 8(1) doi: 10.1186/s13287-016-0469-y
|
| 52 |
L. Farzin, S. Asghari, M. Rafraf, M. Asghari-Jafarabadi, M. Shirmohammadi. No beneficial effects of resveratrol supplementation on atherogenic risk factors in patients with nonalcoholic fatty liver disease. International Journal for Vitamin and Nutrition Research 2020; 90(3-4): 279 doi: 10.1024/0300-9831/a000528
|
| 53 |
Corinn Marakovits, Heather Francis. Unraveling the complexities of fibrosis and ductular reaction in liver disease: pathogenesis, mechanisms, and therapeutic insights. American Journal of Physiology-Cell Physiology 2024; 326(3): C698 doi: 10.1152/ajpcell.00486.2023
|
| 54 |
Shahla Rezaei, Masoumeh Akhlaghi, Mohammad Reza Sasani, Reza Barati Boldaji. Olive oil lessened fatty liver severity independent of cardiometabolic correction in patients with non-alcoholic fatty liver disease: A randomized clinical trial. Nutrition 2019; 57: 154 doi: 10.1016/j.nut.2018.02.021
|
| 55 |
Junbo Gao, Lifeng Zhang, Gaiqing Yu, Guoqiang Qu, Yanfeng Li, Xuebing Yang. Model with the GBDT for Colorectal Adenoma Risk Diagnosis. Current Bioinformatics 2020; 15(9): 971 doi: 10.2174/1574893614666191120142005
|
| 56 |
Ali Mehmood Alkassar, Batool Abed Alnaby Shaker Alaboudy. Effect of added different levels of Graviola Leavs meal ( Annona
muricata L) on biochemical blood traits and bacteriological account in broilers chicken. IOP Conference Series: Earth and Environmental Science 2021; 735(1): 012023 doi: 10.1088/1755-1315/735/1/012023
|
| 57 |
Reem Hatem, Faisal A Nawaz, Ghadah A Al-Sharif, Mohammad Almoosa, Wid Kattan, Christos Tzivinikos, E Lila Amirali, Ammar Albanna. Nonalcoholic Fatty Liver Disease in Children and Adolescents Taking Atypical Antipsychotic Medications: Protocol for a Systematic Review and Meta-analysis. JMIR Research Protocols 2022; 11(3): e20168 doi: 10.2196/20168
|
| 58 |
Hyung-Jin Yoo, Jong-Ha Lee, Soo-Kyung Lee, Yung-Sun Song. Effects ofBangkibokryeong-tang(Fangjifuling-tang) on the Reduction of Blood Glucose and Body Fat in High Fat Diet Induced Obese Mice. Journal of Korean Medicine Rehabilitation 2017; 27(1): 1 doi: 10.18325/jkmr.2017.27.1.1
|
| 59 |
Ram B. Jain, Alan Ducatman. Selective Associations of Recent Low Concentrations of Perfluoroalkyl Substances With Liver Function Biomarkers. Journal of Occupational & Environmental Medicine 2019; 61(4): 293 doi: 10.1097/JOM.0000000000001532
|
| 60 |
Sajida Perveen, Muhammad Shahbaz, Karim Keshavjee, Aziz Guergachi. A Systematic Machine Learning Based Approach for the Diagnosis of Non-Alcoholic Fatty Liver Disease Risk and Progression. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-20166-x
|
| 61 |
Rishi Rikhi, Tavankit Singh, Jamak Modaresi Esfeh. Work up of fatty liver by primary care physicians, review. Annals of Medicine and Surgery 2020; 50: 41 doi: 10.1016/j.amsu.2020.01.001
|
| 62 |
Nengguang Fan, Xiaoying Ding, Qin Zhen, Liping Gu, Aifang Zhang, Tingting Shen, Yufan Wang, Yongde Peng. Association of the Non‐Alcoholic Fatty Liver Disease Fibrosis Score with subclinical myocardial remodeling in patients with type 2 diabetes: A cross‐sectional study in China. Journal of Diabetes Investigation 2021; 12(6): 1035 doi: 10.1111/jdi.13430
|
| 63 |
Masoumeh Atefi, Mohammad Hassan Entezari, Hamid Vahedi, Akbar Hassanzadeh, Marta Laranjo. Sesame Oil Ameliorates Alanine Aminotransferase, Aspartate Aminotransferase, and Fatty Liver Grade in Women with Nonalcoholic Fatty Liver Disease Undergoing Low-Calorie Diet: A Randomized Double-Blind Controlled Trial. International Journal of Clinical Practice 2022; 2022: 1 doi: 10.1155/2022/4982080
|
| 64 |
M.S. Abdelbary, R. Marzaban, H. Gamal Eldeen, M. Khairy, M. Menesy, M.H. Fahmy, A.M. Ayad, B.S. Mouheb, A. Yosry. La utilidad clínica de la elastografía transitoria como una herramienta de imagenología para evaluar el impacto a corto plazo de la gastrectomía laparoscópica en manga, en conjunto con parámetros clínicos y bioquímicos e índices clínico-bioquímicos en pacientes con enfermedad de hígado graso no alcohólico: un estudio piloto egipcio. Revista de Gastroenterología de México 2021; 86(2): 125 doi: 10.1016/j.rgmx.2020.04.007
|
| 65 |
Cari Coscia, Ernest Saxton, Sharon Dickinson. Postoperative Care of a Liver Transplant Recipient Using a Classification System. Critical Care Nursing Quarterly 2016; 39(3): 252 doi: 10.1097/CNQ.0000000000000119
|
| 66 |
Simona Alexandra Iacob, Diana Gabriela Iacob. Non-Alcoholic Fatty Liver Disease in HIV/HBV Patients – a Metabolic Imbalance Aggravated by Antiretroviral Therapy and Perpetuated by the Hepatokine/Adipokine Axis Breakdown. Frontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.814209
|
| 67 |
Saverio Nucera, Rosa Maria Bulotta, Stefano Ruga, Rosamaria Caminiti, Maria Serra, Roberto Bava, Fabio Castagna, Carmine Lupia, Mariangela Marrelli, Filomena Conforti, Giancarlo Statti, Vincenzo Mollace, Ernesto Palma. Natural Products for the Treatment of Non-Alcoholic Fatty Liver Disease: A Comprehensive Review. Scientia Pharmaceutica 2023; 91(4): 53 doi: 10.3390/scipharm91040053
|
| 68 |
Hua Cai, Yue-Lan Qin, Ze-Ya Shi, Jin-Hui Chen, Min-Jie Zeng, Wei Zhou, Ru-Qun Chen, Zhi-Yuan Chen. Effects of alternate-day fasting on body weight and dyslipidaemia in patients with non-alcoholic fatty liver disease: a randomised controlled trial. BMC Gastroenterology 2019; 19(1) doi: 10.1186/s12876-019-1132-8
|
| 69 |
Charlotte S Benson, Jeremy F Cobbold, Charlotte J Frise. Non-alcoholic fatty liver disease in pregnancy. Obstetric Medicine 2023; 16(2): 116 doi: 10.1177/1753495X211034709
|
| 70 |
Manuel F. Landecho, Víctor Valentí, Rafael Moncada, Gema Frühbeck. Obesity and Lipotoxicity. Advances in Experimental Medicine and Biology 2017; 960: 529 doi: 10.1007/978-3-319-48382-5_23
|
| 71 |
Almudena Veiga-Lopez, Yong Pu, Jeremy Gingrich, Vasantha Padmanabhan. Obesogenic Endocrine Disrupting Chemicals: Identifying Knowledge Gaps. Trends in Endocrinology & Metabolism 2018; 29(9): 607 doi: 10.1016/j.tem.2018.06.003
|
| 72 |
Ann Hammarstedt, Silvia Gogg, Shahram Hedjazifar, Annika Nerstedt, Ulf Smith. Impaired Adipogenesis and Dysfunctional Adipose Tissue in Human Hypertrophic Obesity. Physiological Reviews 2018; 98(4): 1911 doi: 10.1152/physrev.00034.2017
|
| 73 |
Timothy D. Rohrbach, Amon Asgharpour, Melissa A. Maczis, David Montefusco, L. Ashley Cowart, Pierre Bedossa, Arun J. Sanyal, Sarah Spiegel. FTY720/fingolimod decreases hepatic steatosis and expression of fatty acid synthase in diet-induced nonalcoholic fatty liver disease in mice. Journal of Lipid Research 2019; 60(7): 1311 doi: 10.1194/jlr.M093799
|
| 74 |
Lucas Zangerolamo, Jean F. Vettorazzi, Lucas R.O. Rosa, Everardo M. Carneiro, Helena C.L. Barbosa. The bile acid TUDCA and neurodegenerative disorders: An overview. Life Sciences 2021; 272: 119252 doi: 10.1016/j.lfs.2021.119252
|
| 75 |
Sonu Subudhi, Hannah K. Drescher, Laura E. Dichtel, Lea M. Bartsch, Raymond T. Chung, Matthew M. Hutter, Denise W. Gee, Ozanan R. Meireles, Elan R. Witkowski, Louis Gelrud, Ricard Masia, Stephanie A. Osganian, Jenna L. Gustafson, Steve Rwema, Miriam A. Bredella, Sangeeta N. Bhatia, Andrew Warren, Karen K. Miller, Georg M. Lauer, Kathleen E. Corey. Distinct Hepatic Gene‐Expression Patterns of NAFLD in Patients With Obesity. Hepatology Communications 2022; 6(1): 77 doi: 10.1002/hep4.1789
|
| 76 |
Minal Patel. Evidence-based management of patients with nonalcoholic fatty liver disease. JAAPA 2022; 35(8): 20 doi: 10.1097/01.JAA.0000840492.53680.59
|
| 77 |
Harleen K. Dyal, Maria Aguilar, Taft Bhuket, Benny Liu, Edward W. Holt, Sharon Torres, Ramsey Cheung, Robert J. Wong. Concurrent Obesity, Diabetes, and Steatosis Increase Risk of Advanced Fibrosis Among HCV Patients: A Systematic Review. Digestive Diseases and Sciences 2015; 60(9): 2813 doi: 10.1007/s10620-015-3760-3
|
| 78 |
Sara Ashtari, Mohamad Amin Pourhoseingholi, Mohamad Reza Zali. Non-alcohol fatty liver disease in Asia: Prevention and planning. World Journal of Hepatology 2015; 7(13): 1788-1796 doi: 10.4254/wjh.v7.i13.1788
|
| 79 |
Extracellular Matrix Remodeling of Adipose Tissue in Obesity and Metabolic Diseases. International Journal of Molecular Sciences 2019; 20(19): 4888 doi: 10.3390/ijms20194888
|
| 80 |
Hui Cheng, Na Xu, Wenxia Zhao, Jingjing Su, Mengru Liang, Zhongwen Xie, Xianli Wu, Qinglin Li. (‐)‐Epicatechin regulates blood lipids and attenuates hepatic steatosis in rats fed high‐fat diet. Molecular Nutrition & Food Research 2017; 61(11) doi: 10.1002/mnfr.201700303
|
| 81 |
Rendong Ren, Zheng Yang, Aili Zhao, Yuyang Huang, Shiying Lin, Junjie Gong, Jie Chen, Pingping Zhu, Fang Huang, Wenting Lin. Sulfated polysaccharide from Enteromorpha prolifera increases hydrogen sulfide production and attenuates non-alcoholic fatty liver disease in high-fat diet rats. Food & Function 2018; 9(8): 4376 doi: 10.1039/C8FO00518D
|
| 82 |
Arkadip Choudhury, Avik Chakraborty, Animesh Saha. STATUS OF 25-HYDROXYVITAMIN D LEVELS AND SERUM CONCENTRATION OF PROINFLAMMATORY CYTOKINES (IL-6 AND TNF-Α) IN MIDDLE-AGED TRIBAL SUBJECTS OF TRIPURA. Journal of Evolution of Medical and Dental Sciences 2018; 7(45): 4847 doi: 10.14260/jemds/2018/1080
|
| 83 |
Wensheng Liu, Robert D. Baker, Tavleen Bhatia, Lixin Zhu, Susan S. Baker. Pathogenesis of nonalcoholic steatohepatitis. Cellular and Molecular Life Sciences 2016; 73(10): 1969 doi: 10.1007/s00018-016-2161-x
|
| 84 |
Saeed Hamid, Amna Subhan Butt, Fatima Sharif, Zishan Haider, Mohammad Salih, Safia Awan, Aatif A Khan, Jaweed Akhter. Nonalcoholic Fatty Liver Diseases among Recently Diagnosed Patients with Diabetes Mellitus and Risk Factors. Euroasian Journal of Hepato-Gastroenterology 2019; 9(1): 9 doi: 10.5005/jp-journals-10018-1288
|
| 85 |
Jinhyuk Na, Soo An Choi, Adnan Khan, Joo Young Huh, Lingjuan Piao, Inah Hwang, Hunjoo Ha, Youngja H Park. Integrative Omics Reveals Metabolic and Transcriptomic Alteration of Nonalcoholic Fatty Liver Disease in Catalase Knockout Mice. Biomolecules & Therapeutics 2019; 27(2): 134 doi: 10.4062/biomolther.2018.175
|
| 86 |
Stephanie Breher-Esch, Nishika Sahini, Anna Trincone, Christin Wallstab, Jürgen Borlak. Genomics of lipid-laden human hepatocyte cultures enables drug target screening for the treatment of non-alcoholic fatty liver disease. BMC Medical Genomics 2018; 11(1) doi: 10.1186/s12920-018-0438-7
|
| 87 |
Masoumeh Akhlaghi. Non-alcoholic Fatty Liver Disease: Beneficial Effects of Flavonoids. Phytotherapy Research 2016; 30(10): 1559 doi: 10.1002/ptr.5667
|
| 88 |
Lizhi Fu, Antje Bruckbauer, Fenfen Li, Qiang Cao, Xin Cui, Rui Wu, Hang Shi, Michael B. Zemel, Bingzhong Xue. Interaction between metformin and leucine in reducing hyperlipidemia and hepatic lipid accumulation in diet-induced obese mice. Metabolism 2015; 64(11): 1426 doi: 10.1016/j.metabol.2015.07.006
|
| 89 |
Anna Radziejewska, Agata Muzsik, Fermín I. Milagro, J. Alfredo Martínez, Agata Chmurzynska. One-Carbon Metabolism and Nonalcoholic Fatty Liver Disease: The Crosstalk between Nutrients, Microbiota, and Genetics. Lifestyle Genomics 2020; 13(2): 53 doi: 10.1159/000504602
|
| 90 |
Naser Khalaji, Ahad Zeinali, Masomeh Purjabali, Kia Bolurani, Amin Abdollahazade Fard. The Effect of Bioactive Component of Turmeric (curcumin) on Liver Complications - Induced by Compact Fluorescent Lamps (CFLs) in Rats. Shiraz E-Medical Journal 2018; (In Press) doi: 10.5812/semj.60572
|
| 91 |
Aayed Alqahtani, Mohamed Elahmedi, Khalid Alswat, Maha Arafah, Mosa Fagih, Jaehoon Lee. Features of nonalcoholic steatohepatitis in severely obese children and adolescents undergoing sleeve gastrectomy. Surgery for Obesity and Related Diseases 2017; 13(9): 1599 doi: 10.1016/j.soard.2017.04.005
|
| 92 |
Love Sharma, Divya Gupta, Sheikh Tasduq Abdullah. Thioacetamide potentiates high cholesterol and high fat diet induced steato-hepatitic changes in livers of C57BL/6J mice: A novel eight weeks model of fibrosing NASH. Toxicology Letters 2019; 304: 21 doi: 10.1016/j.toxlet.2019.01.001
|
| 93 |
Momoka Yamaguchi, Naoki Dohi, Akira Ooka, Shin-ya Saito, Tomohisa Ishikawa. Caffeine-induced inversion of prostaglandin E2 effects on hepatic stellate cell activation. Biomedicine & Pharmacotherapy 2021; 142: 111989 doi: 10.1016/j.biopha.2021.111989
|
| 94 |
A Al-Radaideh, R Tayyem, K Al-Fayomi, N Nimer, A Almomani, S Alhajjaj, L Agraib, N Hijjawi. The association of hepatic fat percentage with selected anthropometric and biochemical parameters at 3-Tesla magnetic resonance imaging. British Journal of Biomedical Science 2019; 76(2): 70 doi: 10.1080/09674845.2019.1571555
|
| 95 |
Somayyeh Asghari, Mohammad Asghari-Jafarabadi, Mohammad-Hossein Somi, Seyed-Mostafa Ghavami, Maryam Rafraf. Comparison of Calorie-Restricted Diet and Resveratrol Supplementation on Anthropometric Indices, Metabolic Parameters, and Serum Sirtuin-1 Levels in Patients With Nonalcoholic Fatty Liver Disease: A Randomized Controlled Clinical Trial. Journal of the American College of Nutrition 2018; 37(3): 223 doi: 10.1080/07315724.2017.1392264
|
| 96 |
Agnieszka Zwolak, Agnieszka Szuster-Ciesielska, Jadwiga Daniluk, Olga Słabczyńska, Martyna Kandefer-Szerszeń, Patricia Aspichueta. Hyperreactivity of Blood Leukocytes in Patients with NAFLD to Ex Vivo Lipopolysaccharide Treatment Is Modulated by Metformin and Phosphatidylcholine but Not by Alpha Ketoglutarate. PLOS ONE 2015; 10(12): e0143851 doi: 10.1371/journal.pone.0143851
|
| 97 |
Martin Duncan, Wenjing Zong, Vincent F. Biank, Joseph R. Hageman. Nonalcoholic Fatty Liver Disease in Pediatrics. Pediatric Annals 2016; 45(2) doi: 10.3928/00904481-20160113-01
|
| 98 |
Sherry Zhang, Chunxia Lu, Arun K. Das, Anil K. Pasupulati, Ram K. Menon. Abrogation of GH action in Kupffer cells results in increased hepatic CD36 expression and exaggerated nonalcoholic fatty liver disease. Growth Hormone & IGF Research 2018; : 74 doi: 10.1016/j.ghir.2018.10.001
|
| 99 |
Gillian Elvira Seipalla, Nurahmi Nurahmi, Ibrahim Abd Samad. Analysis of Liver Fibrosis Degree with APRI Score and FIB-4 Index on Patients with Non-Alcoholic Fatty Liver Disease. INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY 2020; 26(2): 158 doi: 10.24293/ijcpml.v26i2.1414
|
| 100 |
Mohammad Hosein Farzaei, Amit Kumar Singh, Ramesh Kumar, Courtney R. Croley, Abhay K. Pandey, Ericsson Coy-Barrera, Jayanta Kumar Patra, Gitishree Das, Rout George Kerry, Giuseppe Annunziata, Gian Carlo Tenore, Haroon Khan, Matteo Micucci, Roberta Budriesi, Saeideh Momtaz, Seyed Mohammad Nabavi, Anupam Bishayee. Targeting Inflammation by Flavonoids: Novel Therapeutic Strategy for Metabolic Disorders. International Journal of Molecular Sciences 2019; 20(19): 4957 doi: 10.3390/ijms20194957
|
| 101 |
Yang Liu, Yiping Li, Jue Wang, Lili Yang, Xiao Yu, Ping Huang, Haiyan Song, Peiyong Zheng. Salvia-Nelumbinis naturalis improves lipid metabolism of NAFLD by regulating the SIRT1/AMPK signaling pathway. BMC Complementary Medicine and Therapies 2022; 22(1) doi: 10.1186/s12906-022-03697-9
|
| 102 |
Paulo Sérgio Loubet Filho, Thayná Gil Santos, Vitória Helena de Oliveira Teixeira Reis, Cynthia Monteiro Santee, Matheus Pereira da Costa, Camila Jordão Cândido, Wander Fernando de Oliveira Filiú, Luciane Candeloro Portugal, Elisvânia Freitas dos Santos. Campomanesia sp. flour attenuates non‐alcoholic fatty liver disease on rats fed with a hypercaloric diet. Journal of Animal Physiology and Animal Nutrition 2020; 104(5): 1575 doi: 10.1111/jpn.13361
|
| 103 |
A Lum Han. Association between Non-Alcoholic Fatty Liver Disease and Dietary Habits, Stress, and Health-Related Quality of Life in Korean Adults. Nutrients 2020; 12(6): 1555 doi: 10.3390/nu12061555
|
| 104 |
Renald Blundell, Joseph Ignatius Azzopardi. Influence of Nutrients, Bioactive Compounds, and Plant Extracts in Liver Diseases. 2021; : 129 doi: 10.1016/B978-0-12-816488-4.00005-X
|
| 105 |
Surbhi Dogra, Debajyoti Das, Sujay K. Maity, Avishek Paul, Priya Rawat, P. Vineeth Daniel, Kausik Das, Souveek Mitra, Partha Chakrabarti, Prosenjit Mondal. Liver-Derived S100A6 Propels β-Cell Dysfunction in NAFLD. Diabetes 2022; 71(11): 2284 doi: 10.2337/db22-0056
|
| 106 |
Mazen Noureddin, José M Mato, Shelly C Lu. Nonalcoholic fatty liver disease: Update on pathogenesis, diagnosis, treatment and the role of S-adenosylmethionine. Experimental Biology and Medicine 2015; 240(6): 809 doi: 10.1177/1535370215579161
|
| 107 |
Oriol Juanola, Sebastián Martínez-López, Rubén Francés, Isabel Gómez-Hurtado. Non-Alcoholic Fatty Liver Disease: Metabolic, Genetic, Epigenetic and Environmental Risk Factors. International Journal of Environmental Research and Public Health 2021; 18(10): 5227 doi: 10.3390/ijerph18105227
|
| 108 |
Yamei Li, Ping Qi, Si-Yuan Song, Yiping Wang, Hailian Wang, Peng Cao, Yu’e Liu, Yi Wang. Elucidating cuproptosis in metabolic dysfunction-associated steatotic liver disease. Biomedicine & Pharmacotherapy 2024; 174: 116585 doi: 10.1016/j.biopha.2024.116585
|
| 109 |
Rishi Philip Mathew, Sudhakar K Venkatesh. Imaging diffuse liver disease. Applied Radiology 2019; : 13 doi: 10.37549/AR2604
|
| 110 |
|
| 111 |
Jake P Mann, Rajiv Goonetilleke, Pat McKiernan. Paediatric non-alcoholic fatty liver disease: a practical overview for non-specialists. Archives of Disease in Childhood 2015; 100(7): 673 doi: 10.1136/archdischild-2014-307985
|
| 112 |
Carla Sá, Ana Rita Oliveira, Cátia Machado, Marisa Azevedo, Cristina Pereira-Wilson. Effects on Liver Lipid Metabolism of the Naturally Occurring Dietary Flavone Luteolin-7-glucoside. Evidence-Based Complementary and Alternative Medicine 2015; 2015: 1 doi: 10.1155/2015/647832
|
| 113 |
Ahmed Ba‐Ssalamah, Nina Bastati, Andreas Wibmer, Romana Fragner, Jacqueline C. Hodge, Michael Trauner, Christian J. Herold, Mustafa R. Bashir, Bernard E. Van Beers. Hepatic gadoxetic acid uptake as a measure of diffuse liver disease: Where are we?. Journal of Magnetic Resonance Imaging 2017; 45(3): 646 doi: 10.1002/jmri.25518
|
| 114 |
Igor V Maev, Aleksey A Samsonov, Liudmila K Palgova, Chavdar S Pavlov, Elena N Shirokova, Elena I Vovk, Kirill M Starostin. Effectiveness of phosphatidylcholine as adjunctive therapy in improving liver function tests in patients with non-alcoholic fatty liver disease and metabolic comorbidities: real-life observational study from Russia. BMJ Open Gastroenterology 2020; 7(1): e000368 doi: 10.1136/bmjgast-2019-000368
|
| 115 |
Arefe Nemati, Zeinab Nikniaz, Ali Mota. Effects of Resveratrol Supplementation on Nonalcoholic Fatty Liver Disease Management. Topics in Clinical Nutrition 2023; 38(2): 144 doi: 10.1097/TIN.0000000000000314
|
| 116 |
Tuukka Taipale, Ilkka Seppälä, Emma Raitoharju, Nina Mononen, Leo-Pekka Lyytikäinen, Thomas Illig, Melanie Waldenberger, Markus Juonala, Nina Hutri-Kähönen, Niku Oksala, Mika Kähönen, Olli Raitakari, Terho Lehtimäki. Fatty liver is associated with blood pathways of inflammatory response, immune system activation and prothrombotic state in Young Finns Study. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-28563-y
|
| 117 |
Shaheen Tomah, Naim Alkhouri, Osama Hamdy. Nonalcoholic fatty liver disease and type 2 diabetes: where do Diabetologists stand?. Clinical Diabetes and Endocrinology 2020; 6(1) doi: 10.1186/s40842-020-00097-1
|
| 118 |
Anthony Pinçon, Olivia De Montgolfier, Nilay Akkoyunlu, Caroline Daneault, Philippe Pouliot, Louis Villeneuve, Frédéric Lesage, Bernard I. Levy, Nathalie Thorin-Trescases, Éric Thorin, Matthieu Ruiz. Non-Alcoholic Fatty Liver Disease, and the Underlying Altered Fatty Acid Metabolism, Reveals Brain Hypoperfusion and Contributes to the Cognitive Decline in APP/PS1 Mice. Metabolites 2019; 9(5): 104 doi: 10.3390/metabo9050104
|
| 119 |
Isabel Freitas, Eleonora Boncompagni, Eleonora Tarantola, Cristian Gruppi, Vittorio Bertone, Andrea Ferrigno, Gloria Milanesi, Rita Vaccarone, M. Enrica Tira, Mariapia Vairetti. In SituEvaluation of Oxidative Stress in Rat Fatty Liver Induced by a Methionine- and Choline-Deficient Diet. Oxidative Medicine and Cellular Longevity 2016; 2016: 1 doi: 10.1155/2016/9307064
|
| 120 |
Lucas Zangerolamo, Gabriela Moreira Soares, Jean Franciesco Vettorazzi, Maria Esméria do Amaral, Everardo Magalhães Carneiro, Sara Teresinha Olalla-Saad, Antonio Carlos Boschero, Helena Cristina Barbosa-Sampaio. ARHGAP21 deficiency impairs hepatic lipid metabolism and improves insulin signaling in lean and obese mice. Canadian Journal of Physiology and Pharmacology 2019; 97(11): 1018 doi: 10.1139/cjpp-2018-0691
|
| 121 |
Chen-Cuang Yao, Yu-Xing Tong, Hua Jiang, Dan-Ru Yang, Xue-Jun Zhang, Ping Zhang, Li Su, Yan-Ying Zhao, Zheng-Wang Chen. Native polypeptide vglycin prevents nonalcoholic fatty liver disease in mice by activating the AMPK pathway. Journal of Functional Foods 2020; 73: 104110 doi: 10.1016/j.jff.2020.104110
|
| 122 |
Zifeng Yang, Ruifeng Tian, Xiao-Jing Zhang, Jingjing Cai, Zhi-Gang She, Hongliang Li. Effects of treatment of non-alcoholic fatty liver disease on heart failure with preserved ejection fraction. Frontiers in Cardiovascular Medicine 2023; 9 doi: 10.3389/fcvm.2022.1120085
|
| 123 |
M.S. Abdelbary, R. Marzaban, H. Gamal Eldeen, M. Khairy, M. Menesy, M.H. Fahmy, A.M. Ayad, B.S. Mouheb, A. Yosry. Clinical utility of transient elastography as an imaging tool to assess the short-term impact of laparoscopic sleeve gastrectomy, together with clinical and biochemical parameters and clinico-biochemical indices, on obese patients with nonalcoholic fatty liver disease: An Egyptian pilot study. Revista de Gastroenterología de México (English Edition) 2021; 86(2): 125 doi: 10.1016/j.rgmxen.2020.04.008
|
| 124 |
Victoria T. Isaksen, Maria A. Larsen, Rasmus Goll, Jon R. Florholmen, Eyvind J. Paulssen. Hepatic steatosis, detected by hepatorenal index in ultrasonography, as a predictor of insulin resistance in obese subjects. BMC Obesity 2016; 3(1) doi: 10.1186/s40608-016-0118-0
|
| 125 |
Maria Luíza R. P. Lima, Laura H. R. Leite, Carolina R. Gioda, Fabíola O. P. Leme, Claudia A. Couto, Cândido C. Coimbra, Virginia H. R. Leite, Teresa Cristina A. Ferrari. A Novel Wistar Rat Model of Obesity-Related Nonalcoholic Fatty Liver Disease Induced by Sucrose-Rich Diet. Journal of Diabetes Research 2016; 2016: 1 doi: 10.1155/2016/9127076
|
| 126 |
Bronwen Williams, Nurun Tania, Lynsey Corless. Non-alcoholic fatty liver disease (NAFLD): survey of awareness and understanding among professionals in secondary care. Gastrointestinal Nursing 2019; 17(Sup6): S22 doi: 10.12968/gasn.2019.17.Sup6.S22
|
| 127 |
Somayyeh Asghari, Soudabeh Hamedi‐Shahraki, Farshad Amirkhizi. Systemic redox imbalance in patients with nonalcoholic fatty liver disease. European Journal of Clinical Investigation 2020; 50(4) doi: 10.1111/eci.13211
|
| 128 |
Satoshi HIRAKO, HyounJu KIM, Yuzuru IIZUKA, Akiyo MATSUMOTO. Fish oil consumption prevents hepatic lipid accumulation induced by high-cholesterol feeding in obese KK mice. Biomedical Research 2024; 45(1): 33 doi: 10.2220/biomedres.45.33
|
| 129 |
Hassan H A-Kader. Lysosomal acid lipase deficiency: a form of non-obese fatty liver disease (NOFLD). Expert Review of Gastroenterology & Hepatology 2017; 11(10): 911 doi: 10.1080/17474124.2017.1343144
|
| 130 |
Alabagi Abdulla, Charity Reynolds, H Hesham A-Kader. Non-Alcoholic Fatty Liver Disease (NAFLD): The Search for a Cure. European Medical Journal 2016; : 93 doi: 10.33590/emj/10314771
|
| 131 |
Tian Shen, Bilin Xu, Tao Lei, Lin Chen, Cuiping Zhang, Zhenhua Ni. Sitagliptin reduces insulin resistance and improves rat liver steatosis via the SIRT1/AMPKα pathway. Experimental and Therapeutic Medicine 2018; doi: 10.3892/etm.2018.6554
|
| 132 |
Min-Yu Chung, Hyo-Jin Kim, Hyo-Kyoung Choi, Jae Ho Park, Jin-Taek Hwang. Black Mulberry Extract Elicits Hepatoprotective Effects in Nonalcoholic Fatty Liver Disease Models by Inhibition of Histone Acetylation. Journal of Medicinal Food 2021; 24(9): 978 doi: 10.1089/jmf.2021.K.0048
|
| 133 |
Hamza Hadi, Roberto Vettor, Marco Rossato. Vitamin E as a Treatment for Nonalcoholic Fatty Liver Disease: Reality or Myth?. Antioxidants 2018; 7(1): 12 doi: 10.3390/antiox7010012
|